Humoral immunity against Francisella tularensis after natural infection

Forty-two subjects with acute tularemia were studied for the occurrence of C-reactive protein (CRP), and 73 subjects with acute tularemia or experience of the disease within the last 11 years were studied for immunoglobulin M (IgM), IgA, and IgG class-specific antibodies, agglutinating antibodies, and complement-fixing antibodies to Francisella tularensis by using an enzyme-linked immunosorbent assay (ELISA), the tube agglutination test, and a complement-fixing ELISA. The incubation time between infection and the outbreak of symptoms varied from 1 to 10 days, averaging 6.5 days. Elevated CRP concentrations were found in all samples taken in the first 6 days of illness, when the antibodies generally were absent. The highest CRP values, up to 165 mg/liter, occurred in the earliest samples and then decreased rapidly, being undetectable (less than 1 mg/liter) from 1 month after the onset of symptoms. Simultaneous though individually varying formation of IgM, IgA, and IgG class-specific antibodies to F. tularensis was demonstrable by ELISA in all the tularemia patients during the acute stage. In most cases, these antibodies appeared 6 to 10 days after the onset of symptoms, i.e., about 2 weeks after infection, reached their highest values at 4 to 7 weeks, and, despite a decreasing trend in their level, were still present 0.5 to 11 years after onset of tularemia, as demonstrable by the agglutination test and by the complement-fixing ELISA. Of the three methods used, ELISA for IgM, IgA, and IgG proved to be the most efficient for the early serodiagnosis of tularemia.

[1]  A. Tärnvik,et al.  Antigen from Francisella tularensis: nonidentity between determinants participating in cell-mediated and humoral reactions , 1984, Infection and immunity.

[2]  T. Lint,et al.  Interaction of C-reactive protein with lymphocytes and monocytes: complement-dependent adherence and phagocytosis. , 1976, Journal of immunology.

[3]  D. McGregor,et al.  Tularaemia in the rat. I. The cellular basis on host resistance to infection. , 1975, Immunology.

[4]  O. Meurman Persistence of immunoglobulin G and immunoglobulin M antibodies after postnatal rubella infection determined by solid-phase radioimmunoassay , 1978, Journal of clinical microbiology.

[5]  G. Thorbecke,et al.  THE LIVER AS THE SITE OF C-REACTIVE PROTEIN FORMATION , 1966, The Journal of experimental medicine.

[6]  Thomas Francis,et al.  SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS , 1930, The Journal of experimental medicine.

[7]  B. D. Thorpe,et al.  PHAGOCYTOSIS AND INTRACELLULAR FATE OF PASTEURELLA TULARENSIS. 3. IN VIVO STUDIES WITH PASSIVELY TRANSFERRED CELLS AND SERA. , 1965, Journal of immunology.

[8]  Hans Carlsson,et al.  Enzyme-Linked Immunosorbent Assay for Immunological Diagnosis of Human Tularemia , 1979, Journal of clinical microbiology.

[9]  P. Brachman,et al.  The tularemia skin test. 325 skin tests in 210 persons: serologic correlation and review of the literature. , 1971, Annals of internal medicine.

[10]  C. Larson,et al.  Infection-Immunity in Tularemia: Specificity of Cellular Immunity , 1972, Infection and immunity.

[11]  H. Gewurz,et al.  Radioimmunoassay of human C-reactive protein and levels in normal sera. , 1976, The Journal of laboratory and clinical medicine.

[12]  P. Koskela,et al.  Cell-mediated and humoral immunity induced by a live Francisella tularensis vaccine , 1982, Infection and immunity.

[13]  A. C. Evans,et al.  Agglutination, Cross-Agglutination, and Agglutinin Absorption in Tularaemia. , 1926 .

[14]  H. Gewurz,et al.  Interactions of C-reactive protein with the complement system. III. Complement-dependent passive hemolysis initiated by CRP , 1975, The Journal of experimental medicine.

[15]  G. Edelman,et al.  Binding properties and specificity of C-reactive protein. , 1967, Proceedings of the National Academy of Sciences of the United States of America.

[16]  N. Stallman,et al.  PROLONGED RUBELLA IgM ANTIBODY RESPONSE , 1974, The Medical journal of Australia.

[17]  M. Tsujimoto,et al.  C-Reactive protein induced agglutination of lipid suspensions prepared in the presence and absence of phosphatidylcholine. , 1980, Journal of biochemistry.

[18]  G. Huldt,et al.  DETECTION BY IMMUNOFLUORESCENCE OF ANTIBODIES TO PARASITIC AGENTS. USE OF CLASS‐SPECIFIC CONJUGATES , 1975, Annals of the New York Academy of Sciences.

[19]  T. Monath Neutralizing antibody responses in the major immunoglobulin classes to yellow fever 17D vaccination of humans. , 1971, American journal of epidemiology.

[20]  P. Branefors,et al.  Enzyme-linked immunosorbent assay for titration of Haemophilus influenzae capsular and O antigen antibodies , 1980, Journal of clinical microbiology.

[21]  J. C. Ransmeier,et al.  The Agglutination Reaction in Tularemia. , 1941 .

[22]  G. Lindberg,et al.  Enzyme-Linked Immunosorbent AssayforImmunological Diagnosis ofHumanTularemia , 1979 .

[23]  M. Leinonen,et al.  Comparison of ELISA and RIA for measurement of pneumococcal antibodies before and after vaccination with 14-valent pneumococcal capsular polysaccharide vaccine. , 1981, Journal of clinical pathology.

[24]  P. Koskela,et al.  Cell-mediated immunity against Francisella tularensis after natural infection. , 1980, Scandinavian journal of infectious diseases.

[25]  R. Edelman,et al.  Persistence of virus-specific IgM and clinical recovery after Japanese encephalitis. , 1976, The American journal of tropical medicine and hygiene.

[26]  M. Pepys C-REACTIVE PROTEIN FIFTY YEARS ON , 1981, The Lancet.

[27]  P. Wilkinson Immunoglobulin patterns of antibodies against Brucella in man and animals. , 1966, Journal of immunology.

[28]  A. Tärnvik,et al.  Phagocytosis and Killing of Francisella tularensis by Human Polymorphonuclear Leukocytes , 1983, Infection and immunity.

[29]  M. Viljanen,et al.  Enzyme-linked immunosorbent assay (ELISA) with bacterial sonicate antigen for IgM, IgA, and IgG antibodies to Francisella tularensis: comparison with bacterial agglutination test and ELISA with lipopolysaccharide antigen. , 1983, The Journal of infectious diseases.